Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 23351-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- AMOTL2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated AMOTL2 antibody (Cat. #23351-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium.
FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis.
Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.
Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway.
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.
Hsa_circ_0024093 accelerates VSMC proliferation via miR-4677-3p/miR-889-3p/USP9X/YAP1 axis in in vitro model of lower extremity ASO.
AMOT130 drives BMP-SMAD signaling at the apical membrane in polarized cells.
Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer.
Ma N, Wibowo YC, Wirtz P, Baltus D, Wieland T, Jansen S
Naunyn-Schmiedeberg's archives of pharmacology 2024 Mar;397(3):1763-1789
Naunyn-Schmiedeberg's archives of pharmacology 2024 Mar;397(3):1763-1789
FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis.
Pan S, Zhu J, Liu P, Wei Q, Zhang S, An W, Tong Y, Cheng Z, Liu F
Theranostics 2023;13(14):5130-5150
Theranostics 2023;13(14):5130-5150
Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.
Evsen L, Morris PJ, Thomas CJ, Ceribelli M
Pharmaceuticals (Basel, Switzerland) 2023 Nov 21;16(12)
Pharmaceuticals (Basel, Switzerland) 2023 Nov 21;16(12)
Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway.
Du Y, Cui R, Tian N, Chen M, Zhang XL, Dai SM
Arthritis research & therapy 2022 Aug 8;24(1):188
Arthritis research & therapy 2022 Aug 8;24(1):188
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.
Kantar D, Mur EB, Mancini M, Slaninova V, Salah YB, Costa L, Forest E, Lassus P, Géminard C, Boissière-Michot F, Orsetti B, Theillet C, Colinge J, Benistant C, Maraver A, Heron-Milhavet L, Djiane A
Scientific reports 2021 Mar 11;11(1):5752
Scientific reports 2021 Mar 11;11(1):5752
Hsa_circ_0024093 accelerates VSMC proliferation via miR-4677-3p/miR-889-3p/USP9X/YAP1 axis in in vitro model of lower extremity ASO.
Zhang X, Wang P, Yuan K, Li M, Shen Y, Que H, Wang Y, Liang W
Molecular therapy. Nucleic acids 2021 Dec 3;26:511-522
Molecular therapy. Nucleic acids 2021 Dec 3;26:511-522
AMOT130 drives BMP-SMAD signaling at the apical membrane in polarized cells.
Brunner P, Hastar N, Kaehler C, Burdzinski W, Jatzlau J, Knaus P
Molecular biology of the cell 2020 Jan 15;31(2):118-130
Molecular biology of the cell 2020 Jan 15;31(2):118-130
Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer.
Guo Z, Wang X, Yang Y, Chen W, Zhang K, Teng B, Huang C, Zhao Q, Qiu Z
Molecular therapy. Nucleic acids 2020 Aug 25;22:179-195
Molecular therapy. Nucleic acids 2020 Aug 25;22:179-195
No comments: Submit comment
No validations: Submit validation data